Lakshmi Pendyala

2.7k total citations
96 papers, 2.3k citations indexed

About

Lakshmi Pendyala is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Lakshmi Pendyala has authored 96 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 42 papers in Oncology and 15 papers in Materials Chemistry. Recurrent topics in Lakshmi Pendyala's work include Metal complexes synthesis and properties (15 papers), Cancer therapeutics and mechanisms (14 papers) and Lanthanide and Transition Metal Complexes (11 papers). Lakshmi Pendyala is often cited by papers focused on Metal complexes synthesis and properties (15 papers), Cancer therapeutics and mechanisms (14 papers) and Lanthanide and Transition Metal Complexes (11 papers). Lakshmi Pendyala collaborates with scholars based in United States, Canada and Australia. Lakshmi Pendyala's co-authors include Patrick J. Creaven, Suzanne Hector, Joseph Zdanowicz, Raymond P. Perez, Kieran L. O’Loughlin, Hans Minderman, Maria R. Baer, Youcef M. Rustum, Kimberly Clark and Patrick F. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Analytical Biochemistry.

In The Last Decade

Lakshmi Pendyala

93 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lakshmi Pendyala United States	27	1.1k	1.1k	337	264	229	96	2.3k
P J O'Dwyer United States	23	1.1k 1.0×	998 0.9×	332 1.0×	440 1.7×	351 1.5×	50	2.3k
Karen R. Grotzinger United States	13	1.6k 1.4×	1.2k 1.1×	183 0.5×	304 1.2×	289 1.3×	18	3.3k
Dona Alberti United States	30	1.4k 1.2×	1.0k 1.0×	419 1.2×	158 0.6×	387 1.7×	90	2.8k
Jacques Jolivet Canada	29	1.7k 1.5×	1.0k 1.0×	411 1.2×	127 0.5×	286 1.2×	91	3.9k
Amanda F. Baker United States	32	1.6k 1.4×	606 0.6×	417 1.2×	167 0.6×	453 2.0×	56	2.7k
Franco Zunino Italy	30	1.5k 1.4×	1.5k 1.4×	298 0.9×	137 0.5×	263 1.1×	73	3.1k
Brent C. Behrens United States	15	1.2k 1.1×	768 0.7×	119 0.4×	189 0.7×	222 1.0×	19	2.1k
William R. Waud United States	30	1.6k 1.4×	606 0.6×	233 0.7×	89 0.3×	186 0.8×	81	2.8k
David J. Kerr United Kingdom	21	748 0.7×	790 0.7×	318 0.9×	372 1.4×	207 0.9×	38	2.4k
Alain Gouyette France	32	1.8k 1.6×	1.2k 1.1×	303 0.9×	246 0.9×	288 1.3×	105	3.2k

Countries citing papers authored by Lakshmi Pendyala

Since Specialization

Citations

This map shows the geographic impact of Lakshmi Pendyala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmi Pendyala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmi Pendyala more than expected).

Fields of papers citing papers by Lakshmi Pendyala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakshmi Pendyala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmi Pendyala. The network helps show where Lakshmi Pendyala may publish in the future.

Co-authorship network of co-authors of Lakshmi Pendyala

This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmi Pendyala. A scholar is included among the top collaborators of Lakshmi Pendyala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmi Pendyala. Lakshmi Pendyala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tummala, Ramakumar, Paula Diegelman, Suzanne Hector, et al.. (2010). Combination effects of platinum drugs and N 1, N 11 diethylnorspermine on spermidine/spermine N 1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants. Cancer Chemotherapy and Pharmacology. 67(2). 401–414. 19 indexed citations

Javle, Milind, Gary Yang, Gregory E. Wilding, et al.. (2009). Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis. Cancer Investigation. 27(2). 193–200. 14 indexed citations

Bailey, Dennis B., Kenneth M. Rassnick, Nathan L. Dykes, & Lakshmi Pendyala. (2009). Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors. American Journal of Veterinary Research. 70(6). 770–776. 19 indexed citations

Fakih, Marwan, Gary Yang, Lakshmi Pendyala, et al.. (2008). Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(3). 650–657. 26 indexed citations

Pendyala, Lakshmi, et al.. (2008). Dysregulation of Purine Nucleotide Biosynthesis Pathways Modulates Cisplatin Cytotoxicity in Saccharomyces cerevisiae. Molecular Pharmacology. 74(4). 1092–1100. 12 indexed citations

Hector, Suzanne, Ramakumar Tummala, Nicholas Kisiel, et al.. (2007). Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N 1 , N 11 diethylnorspermine. Cancer Chemotherapy and Pharmacology. 62(3). 517–527. 24 indexed citations

Fakih, Marwan, Lakshmi Pendyala, William E. Brady, et al.. (2007). A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors. Cancer Chemotherapy and Pharmacology. 62(3). 499–508. 31 indexed citations

González-Covarrubias, Vanessa, Debashis Ghosh, Sukhwinder S. Lakhman, Lakshmi Pendyala, & Javier G. Blanco. (2007). A Functional Genetic Polymorphism on Human Carbonyl Reductase 1 (CBR1 V88I) Impacts on Catalytic Activity and NADPH Binding Affinity. Drug Metabolism and Disposition. 35(6). 973–980. 52 indexed citations

Hector, Suzanne, et al.. (2006). Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10. Cancer Letters. 245(1-2). 195–204. 11 indexed citations

10.

Hector, Suzanne, William R. Greco, Kimberly Clark, et al.. (2006). Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 59(6). 711–723. 21 indexed citations

11.

Leichman, Lawrence, David Lawrence, Cynthia G. Leichman, et al.. (2006). Expression of Genes Related to Activity of Oxaliplatin and 5-Fluorouracil in Endoscopic Biopsies of Primary Esophageal Cancer in Patients Receiving Oxaliplatin, 5-Flourouracil and Radiation: Characterization and Exploratory Analysis with Survival. Journal of Chemotherapy. 18(5). 514–524. 12 indexed citations

12.

Ramnath, Nithya, Nikhil I. Khushalani, Károly Tóth, et al.. (2005). S-phase modulation by irinotecan: pilot studies in advanced solid tumors. Cancer Chemotherapy and Pharmacology. 56(5). 447–454. 11 indexed citations

13.

Minderman, Hans, Kieran L. O’Loughlin, Patrick F. Smith, et al.. (2005). Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 57(1). 73–83. 6 indexed citations

14.

Pendyala, Lakshmi, Gary N. Schwartz, Patrick F. Smith, et al.. (2003). Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy. Cancer Chemotherapy and Pharmacology. 51(5). 376–384. 12 indexed citations

15.

Hector, Suzanne, et al.. (2001). In vitro studies on the mechanisms of oxaliplatin resistance. Cancer Chemotherapy and Pharmacology. 48(5). 398–406. 137 indexed citations

16.

Madajewicz, Stefan, Daniela Matei, Andrzej P. Kudelka, et al.. (1999). Actual 5-Year Survival of Patients with Stage IIIB Breast Carcinoma: Phase II Trial of Methotrexate, Vinblastine, Adriamycin, Cisplatin, and Folinic Acid. Cancer Investigation. 17(7). 463–467. 4 indexed citations

17.

El-Akawi, Zeyad, Raymond P. Perez, Joseph S. Glavy, et al.. (1996). Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. Cancer Letters. 105(1). 5–14. 63 indexed citations

18.

Pendyala, Lakshmi, et al.. (1989). Uptake and metabolism of iproplatin in murine L1210 cells. Cancer Chemotherapy and Pharmacology. 25(1). 15–18. 8 indexed citations

19.

Pendyala, Lakshmi, et al.. (1988). Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostate. Cancer Chemotherapy and Pharmacology. 22(1). 69–76. 10 indexed citations

20.

Madajewicz, Stefan, Lakshmi Pendyala, Hiroshi Takita, et al.. (1987). Phase I clinical trial of 1-2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl-3-(4-carboxy-phenyl)urea (CGP 15720A). Cancer Chemotherapy and Pharmacology. 20(2). 145–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact